Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.

[1]  M. Hori,et al.  β-Adrenoceptor Blocker Carvedilol Provides Cardioprotection via an Adenosine-Dependent Mechanism in Ischemic Canine Hearts , 2004, Circulation.

[2]  H. Ogawa,et al.  Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. , 2003, The American journal of cardiology.

[3]  S. Hosoda,et al.  Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. , 2004, American heart journal.

[4]  Å. Hjalmarson.  METOPROLOL IN ACUTE MYOCARDIAL INFARCTION , 1982, The Lancet.

[5]  Eva Kline-Rogers,et al.  Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. , 2004, The American journal of medicine.

[6]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[7]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[8]  Y. Hayashi,et al.  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.

[9]  K. Anstrom,et al.  National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. , 2006, American heart journal.

[10]  J. Herlitz.  Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group. , 1985, The American journal of cardiology.

[11]  S. Kernis,et al.  Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? , 2004, Journal of the American College of Cardiology.

[12]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[13]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[14]  S. Kopecky.  Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. , 2006, The American journal of cardiology.

[15]  Harlan M Krumholz,et al.  Impact of medication therapy discontinuation on mortality after myocardial infarction. , 2006, Archives of internal medicine.

[16]  H. Krumholz,et al.  Are β-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? , 2000 .

[17]  J. Senges,et al.  The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction , 2010, Heart.

[18]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[19]  H. Krumholz,et al.  Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? , 2000, Archives of internal medicine.

[20]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[21]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.

[22]  S. Ito,et al.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease , 2007, Clinical and Experimental Nephrology.

[23]  R. Goldberg,et al.  Discrepancies in the use of medications: their extent and predictors in an outpatient practice. , 2000, Archives of internal medicine.

[24]  ISIS-1 Collaborative Group.  RANDOMISED TRIAL OF INTRAVENOUS ATENOLOL AMONG 16 027 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-1 , 1986, The Lancet.

[25]  Ralph D'Agostino,et al.  Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.

[26]  K. Swedberg,et al.  The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. , 1983, Circulation.

[27]  Gervasio A. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[28]  L. Green,et al.  ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction. , 2009, American family physician.

[29]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[30]  Dwight Lemon,et al.  Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .